TC
TWST icon

Truvestments Capital’s Twist Bioscience TWST Stock Holding History

Truvestments Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Hold
1,773
– – 0.03% 338
2026
Q1 		$84.3K Hold
1,773
– – 0.02% 413
2025
Q4 		$56.2K Buy
1,773
+1,109
+167% +$34.6K 0.01% 428
2025
Q3 		$18.7K Buy
664
+160
+32% +$4.85K ﹤0.01% 610
2025
Q2 		$18.5K Buy
+504
New +$17.4K ﹤0.01% 549

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Truvestments Capital's TWST Position: Q2 2026 in Review

Truvestments Capital held its Twist Bioscience (TWST) position steady in Q2 2026 at 1,773 shares worth $182K. The position accounts for 0.03% of the portfolio, ranked #338.

Truvestments Capital first reported a position in TWST in Q2 2025 and has held it in 5 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Truvestments Capital held 1,773 shares of Twist Bioscience worth $182K as of Q2 2026.
  • Truvestments Capital left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up 0.03% of Truvestments Capital's portfolio in Q2 2026, its #338 holding.
  • Truvestments Capital first reported a position in Twist Bioscience in Q2 2025 and has held it in 5 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.